Ross H. Lowe

Δ9-Tetrahydrocannabinol (THC), 11-Hydroxy-THC, and 11-Nor-9-carboxy-THC Plasma Pharmacokinetics during and after Continuous High-Dose Oral THC

Eugene W Schwilke, David M. Schwope, Erin L Karschner et al. · Clinical Chemistry · 2009 · 116 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +7

Extended urinary Δ9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure

Ross H. Lowe, T. T. Abraham, W. D. Darwin et al. · Drug and Alcohol Dependence · 2009 · 112 citations

Pharmacy, Pharmacology, Toxicology +13

Do Δ⁹‐tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?

Erin L Karschner, Eugene W Schwilke, Ross H. Lowe et al. · Addiction · 2009 · 106 citations

Nursing, Pharmacology, Toxicology +15

Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry

Garry Milman, Allan J. Barnes, Ross H. Lowe et al. · Journal of Chromatography A · 2010 · 102 citations · Full text

Pharmacy, Pharmaceutical Analysis, Pharmacology +12

Simultaneous quantification of Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol, and 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry

Ross H. Lowe, Erin L Karschner, Eugene W Schwilke et al. · Journal of Chromatography A · 2007 · 73 citations

Pharmacy, Biochemistry, Pharmacology +15